A high-throughput screening protocol has been developed for Mycobacterium tuberculosis glutamine synthetase by quantitative estimation of inorganic phosphate. The K m values determined at pH 6.8 are 22 mM for L-glutamic acid, 0.75 mM for NH 4 Cl, 3.25 mM for MgCl 2 , and 2.5 mM for adenosine triphosphate. The K m value for glutamine is affected significantly by the increase in pH of assay buffer. At the saturating level of the substrate, the enzyme activity at pH 6.8 and 25° C is found to be linear up to 3 h. The reduction of enzyme activity is negligible even in presence of 10% DMSO. The Z′ factor and signal-to-noise ratio are found to be 0.75 and 6.18, respectively, when the enzyme is used at 62.5 µg/ml concentration. The IC 50 values obtained at pH 6.8 for both L-methionine S-sulfoximine and DL-phosphothriacin are 500 µM and 30 µM, respectively, which is lowest compared to the values obtained at other pH levels. The Beckman Coulter high-throughput screening platform was found to take 5 h 9 min to complete the screening of 60 plates. For each assay plate, a replica plate is used to normalize the data. Screening of 1164 natural product fractions/extracts and synthetic molecules from an in-house library was able to identify 12 samples as confirmed hits. Altogether, the validation data from screening of a small set of an in-house library coupled with Z′ and signalto-noise values indicate that the protocol is robust for high-throughput screening of a diverse chemical library. (Journal of Biomolecular
INTRODUCTION T HE WORLD HEALTH ORGANIZATION has estimated that
Mycobacterium tuberculosis is the single infectious agent that causes about 2 to 3 million deaths annually. 1 Every 10 s, 1 person dies of tuberculosis. 2 One third of the world's population is latently infected by the pathogen without any symptoms of the diseases but has the possibility for the infection to be reactivated any time in their life. 3 In some parts of the world, the proportion of the multidrug-resistant strains has been increasing alarmingly. 4 HIV-infected patients are particularly susceptible to M. tuberculosis. 5 In the past 40 years, no new drug has been discovered for combating tuberculosis. 6 There is an urgent medical need to discover and develop novel therapeutic agents against M. tuberculosis.
Inhibitors of some of the targets that have been suggested in the recent literature might lead to the development of novel drugs against the pathogen. [7] [8] [9] [10] [11] [12] [13] Glutamine synthetase is one such target for the disease. [14] [15] [16] [17] [18] [19] Extracellular glutamine synthetase is an essential enzyme for the survival of M. tuberculosis. [15] [16] [17] [18] [19] This enzyme is secreted by all pathogenic mycobacteria. It is suggested that this extracellular enzyme functions in the regulation of ammonia in the phagosomal compartment as well as synthesis of the cell wall component. 17 Inhibition of extracellular enzyme activity in M. tuberculosis culture, in infected THP-1 cells as well as in the in vivo condition of the guinea pig model by the substrate analogs, showed the potential of glutamine synthetase as a drug target against tuberculosis. 19 The 3-dimensional structure of the enzyme has also been extensively studied. [20] [21] [22] Conventionally, glutamine synthetase activity is monitored through biosynthetic as well as transfer assays. 23, 24 A high-throughput assay has already been developed based on transfer activity. 23 The components involved in biosynthetic activity are different from the components of transfer activity of the enzyme. 23, 24 The enzyme participates in biosynthetic activity only under in vivo conditions in which L-glutamic acid, ammonia and adenosine triphosphate (ATP) participate as substrates to generate L-glutamine, adenosine diphosphate (ADP), and Pi. 23, 24 So, even though L-methionine S-sulfoximine and DL-phosphothriacin inhibit the activities of the enzyme, finding true inhibitors for in vivo efficacy could become very difficult if they are picked up by screening using the transfer assay. 23 Development of a high-throughput screening (HTS) assay protocol based on biosynthetic activity of the enzyme for identifying novel chemical structure against M. tuberculosis has immense importance in the current situation.
The present study evaluates the kinetic properties of M. tuberculosis glutamine synthetase in biosynthetic activity as well as converts it to a robust high-throughput assay protocol for screening of a chemically diverse synthetic and natural product library.
MATERIALS AND METHODS

Materials
All the chemicals were obtained from Sigma. A Beckman Coulter platform integrated with Biomek 2000, ORCA Robot, Thermo Forma CO 2 incubator, Shaker and BMG POLARStar was used to conduct screening of an in-house library obtained from natural product fractions using SEP BOX from Sepiatek, Germany, and synthetic compounds from an in-house depository. A Cary 50 Bio Spectrophotometer was used to carry out the initial standardization of biosynthetic experiments.
Purification of the enzyme
The enzyme was purified from recombinant Escherichia coli strain YMC21E by using a modified method. 23 The enzyme preparation was used for further standardization and characterization of the enzyme for biosynthetic activity of the enzyme as well as development of the HTS screening protocol.
Transfer assay
The monitoring of γ-glutamylhydroxamate production due to the conversion of L-glutamine and hydroxylamine by glutamine synthetase is called a transfer assay. The transfer assay was carried out to check the enzyme activity in crude extract using 20 mM imidazole buffer pH 7.0, 300 mM L-glutamine, 60 mM hydroxylamine, 20 µM ADP, 50 µM NaAsO 4 , and 250 µm MnCl 2 . The stop reagent, containing FeCl 3 (5%), TCA (24%), and HCL (0.6 N), was added to stop the reaction as well as to form the purplish complex between γ-glutamylhydroxamate and FeCl 3 in the acidic condition. 23
Biosynthetic assay
A modified protocol was followed to carry out M. tuberculosis glutamine synthetase biosynthetic assay, as described earlier. 24 The reaction was started by adding 7.6 mM of ATP in 200 µl of reaction mixture containing 20 mM imidazole buffer pH 7.0, 100 mM L-glutamic acid, 50 mM MgCl 2 , 50 mM NH 4 Cl, and sufficient amount of enzyme in a test tube. In this reaction, ammonium chloride, L-glutamic acid, and ATP were used as substrate and Mg 2+ ion as a cofactor to yield inorganic phosphate, glutamine, and ammonia. In the modified protocol, to stop the reaction, 12% w/v L-ascorbic acid in 1 N HCL and 2% w/v ammonium molybdate in ddH 2 O were mixed in a 2:1 proportion, and 600 µl of that was added to 200 µl of reaction mixture and mixed well to develop a blue color immediately. 25 It was incubated for 7 min to get the fully developed color. After that, 600 µl of 1% sodium citrate tribasic dihydrate in 1% acetic acid in ddH 2 O was added to the reaction mixture to restrict the further development of color due to hydrolysis of ATP. 25 Incubation of the reaction mixture with 22.5 mM EDTA served as the blank. A Cary 50 Bio Spectrophotometer was used to monitor the color at 655 nm after a 30-min incubation.
At pH 6.8, K m values for substrates were determined in 50 mM HEPES buffer in the presence of 62.5 µg/ml of enzyme using increasing concentrations of L-glutamic acid (4.0 to 256 mM) and ammonium chloride (0.25 to 16.0 mM), respectively, keeping magnesium chloride (25 mM) and ATP (7.6 mM) at the saturating level. Similarly, the K m values of L-glutamic acid and ammonium chloride were determined in Tris-acetate buffer pH 6.5 using increasing concentrations from 16 to 256 mM and 0.03125 to 4.0 mM, respectively, keeping magnesium chloride (70 mM) and ATP (4 mM) at the saturating level. We observed that Tris-acetate buffer does not have any significant effect on enzyme activity. At pH 7.5, when the concentrations of L-glutamic acid and ammonium chloride were varied from 2 to 256 mM and 0.5 to 32 mM, respectively, the concentrations of magnesium chloride (25 mM) and ATP (15 mM) were kept at the saturating level in 50 mM HEPES buffer. For the determination of K m values at pH 8.0, varying concentrations of L-glutamic acid and ammonium chloride were used from 25 to 1000 mM and 0.25 to 16 mM at the saturating level of magnesium chloride (25 mM) and ATP (10 mM) in HEPES buffer. A Hanes-Wolf plot was drawn to find the K m values of the respective components separately at all 4 different pH levels, as mentioned above. Considering the physiological relevance and determined K m values, it was decided that a pH level of 6.8 would be used for further development of screening protocol.
The final assay mix contained 50 mM HEPES buffer pH 6.8, 220 mM L-glutamic acid (pH adjusted to 6.8), 7.5 mM NH 4 Cl, 32.5 mM MgCl 2 , and 62.5 µg/ml enzyme. The reaction was started by adding 7.6 mM ATP (pH adjusted ∼ 6.8) in the reaction mixture and incubated for 2 h at 25° C. Adding stop reagent terminated the reaction, and citrate was added within 10 min. The whole mixture was kept at room temperature for another 30 min prior to reading the color using a 620-nm filter.
HTS protocol
The assay plates were made by adding 5 µl of samples in DMSO at 10 mg/ml concentration to the respective wells according to the following plate map. Five microliters of DMSO was added to the control and blank wells. Five microliters of 420 mM EDTA was added in the blank wells. The same volume of water was added to the other wells, and then 80 µl of the reaction mix was added to all the wells. The plate was kept on the shaker for 2 min for proper mixing. Then, 10 µl of 76 mM working solution of ATP was added to all wells to start the reaction. After incubation, 75 µl stop reagent was added and allowed to develop the color for approximately 7 min. The reading was taken after 30 min of the addition of 75 µl sodium citrate in the reaction mix using 620-nm filters in the BMG POLARStar. The Z′ factor was determined by following a published procedure. 26 L-methionine S-sulfoximine and DL-phosphothriacin are 2 known inhibitors that were used to further validate the assay. Using a varied concentration of the inhibitor ranging from 0.125 mM to 5 mM, dose-response curves were plotted at the different pH levels mentioned earlier. A total of 1070 natural products and 94 synthetic compounds including 7 standard antibiotics including rifampicin were screened as single-point data using 0.5 mg/ml concentrations in the final assay mix.
Adoption of the protocol to the Beckman Coulter HTS system was done using SAMI software. The program includes the following steps: 1) transfer of a set of 3 assay plates containing 5 µl of compound solutions of 10 mg/ml concentration DMSO/EDTA/ water from the carousel to Biomek 2000, 2) addition of 80 µl of reaction mix to all wells, 3) starting the reaction by adding 10 µl of ATP, 4) moving the plates to the shaker for 30 s, 5) moving the plates to the carousal again for a 2-h incubation at room temperature, 6) moving the plates to Biomek 2000 for an addition of 75 µl of stop reagent, 7) moving the plates to the BMG POLARStar for reading, and 8) returning the plates to the carousel.
Replica plate
The library consists of plant extracts and fractions, many of which are colored and interfere with the readings obtained in the assay plate. It becomes very difficult to identify the real inhibitors from the screening data. To get the readings in assay plates corrected for the color interference, the same screening is carried out with an identical plate map and other conditions except the addition of inhibitors. The inhibitors in the replica plate are added after the reaction is terminated. For presenting the data, the plate reader needs to have a template assigned with blank, control and sample for the respective wells mentioned in the plate map. After reading the plate, the values for each well are shown after deducting the average value obtained from blank wells. The reading from the replica plate is used to normalize the reading, obtained in the corresponding assay plate. The following formula is used to estimate the inhibition by the sample:
where (S) A is the sample reading in the assay plate, (S) R is the sample reading in the replica plate, (C) R is the reading of the control in the replica plate, and (C) A is the reading of the control in the assay plate.
RESULTS
Rapid development and stability of color are considered the most valuable aspects in accepting any absorbance-based assay principle for developing a high-throughput assay protocol. The colorimetric estimation of phosphate typically involves the interaction of phosphate, molybdate, and reducing agents or dyes to produce a colored complex. 25 The reduction of the phosphomolybdate complex in a strong acid solution results in a formation of molybdenum blue. Numerous assays for quantitating phosphate, based on this reaction, have been developed with varying sensitivities and applications, mainly by altering the nature of the reducing agent. 27 Similarly, in the glutamine synthetase biosynthetic assay, ferrous sulfate was used conventionally as a reducing agent for Pi detection. 24 The crux of the assay system was a continuous increase in color due to the hydrolysis of ATP. 25 The major objective during the development of the screening protocol was to control the rate of ATP hydrolysis as well as to increase the sensitivity range with respect to Pi concentration. In this protocol, the reducing agent was changed from FeSO 4 to ascorbic acid for rapid development of color in a highly acidic condition. Once the color was developed, sodium citrate was used to control the hydrolysis of ATP. In this process, the increase in color was confined to a negligible extent of 3% to 4% up to 50 min after the addition of sodium citrate in the reaction mix ( Fig. 1) . Recently, it was clearly shown that the K m values for all the components of M. tuberculosis glutamine synthetase participating in the transfer assay are higher than for other bacterial enzymes. 23 The enzyme obtained from other bacterial sources characteristically depends on Mg 2+ for its biosynthetic activity and mainly on Mn 2+ for the transfer activity. 24 An earlier report on the enzyme activity purified from extracellular medium of M. tuberculosis culture indicated that the optimum pH levels for biosynthetic and transfer activities are 7.5 and 7.0, respectively. 15 To get a broader picture of the pattern of substrates and cofactor use by this recombinant M. tuberculosis glutamine synthetase, the K m values were determined at 4 different pH levels ranging from 8.0 to 6.5 ( Table 1) .
Biosynthetic Activity of Mycobacterium tuberculosis Glutamine Synthetase
The enzyme was purified from recombinant E. coli strain YMC21E by following an earlier published method. 23 More than 90% pure enzyme was used for the determination of K m of all the substrates and cofactor required in the biosynthetic assay (Fig. 2) . Hanes-Wolf plots were drawn to find the K m values of all the constituents of assay mixture. The results indicated that the affinity for both L-glutamic acid and ATP is highest at pH 6.8. The K m for other constituents remained within a narrow range with respect to pH, ranging from 6.8 to 8.0. As the pH dropped further to 6.5, the most significant change observed was the dramatic decrease in K m values of ATP (Table 1) . Otherwise, the K m values for L-glutamic acid and MgCl 2 started increasing again when the pH was changed from 6.8 to 6.5. Biosynthetic activity of M. tuberculosis glutamine synthetase is not supported by any other metal ions except Mg 2+ (data not shown).
Validation
Linearity of the assay, effect of DMSO, and the inhibition of enzyme activity were monitored to validate the HTS format in a 96-well plate. The activity was monitored for 3 h at 37° C and 25° C, respectively, to check the linearity of the assay (Fig. 3A) . The results indicated that the enzyme activity was found to be linear at least for 3 h at 25° C and for only 60 min at 37°C.
To assess the robustness of the assay protocol in microplate format, the Z′ factors as well as signal-to-noise (S/N) ratios were determined with varying enzyme concentrations ( Table 2 ). The results clearly indicated that the enzyme activity was linearly increasing with respect to enzyme concentration in the assay mix. As 62.5 µg/ml protein in 100 µl volume showed the best results with respect to Z′ factor and S/N ratio, the same was used to carry out the screening protocol.
The effect of DMSO was checked to decide the volume of compound solution to be used for screening. The results showed that the enzyme activity was not changed significantly even at 10% DMSO concentration (Fig. 3B) . Mixing of reagents for 30 s on a shaker was required to obtain uniformity in readings (data not shown). The dose-response effect of L-methionine S-sulfoximine and phosphothriacin was checked to find IC 50 values at pH 6.5, 6.8, 7.5, and 8.0 (Fig. 4A, B) . The IC 50 values obtained for both L-methionine S-sulfoximine and DL-phosphothriacin were found to be 500 µM and 30 µM, respectively, at pH 6.8. When the assay was carried out at pH 7.5 and 8.0, respectively, using all the components of the assay mix with respect to their K m values, the IC 50 values increased with pH ( Table 3) . This indicated that the affinities of the standard inhibitors are higher at pH 6.8 and that the increased sensitivity could be helpful in identifying even weak inhibitors from random screening. Both the plate and tube assay have shown an almost similar result, which is indicative of true adoption of the assay in plate format.
A chemically diverse library consisted of extract/fractions from medicinal plants as well as synthetic compounds. These samples were often poorly soluble in aqueous phase or interfered with the absorbance or fluorescence of the analyte in the reaction mixture. To avoid this type of color interference, another plate with an identical plate map was used in which the compound was added at the end of the reaction before taking the readout. This calculation makes it very easy to pick up the actives from the natural product/synthetic library with better estimation of the inhibition profile (equation 1). When the assay protocol was run on the Beckman Coulter HTS system, it was found that the system would take 2 h 47 min for 12 plates. The utilization time for 30 assay and replica plates, each using the same program, was 5 h 9 min, as indicated by SAMI software (data not shown).
The inhibition profile obtained from the assay plates after screening 1164 samples was corrected by using the data from replica plates and using a formula (equation 1). The inhibition data for all compounds are shown as a scatter plot with regard to the respective compounds (Fig. 5A) . The major reason for selecting 500 µg/ml concentrations of the samples for screening is the varied composition of the active ingredient in the crude extracts and fractions obtained from medicinal plants. Even after use of a 500 µg/ml concentration, most of the compounds belong in the range in which negligible affect is observed. The result clearly justified the use of such high concentrations of samples in screening the assay. The histogram of the same data confirmed the earlier observation as well as the robustness of the screening protocol ( Fig. 5B) . Of 1164 samples screened, only 29 showed greater than 40% inhibition. The confirmation experiment was carried out using a fresh stock solution of the hits obtained from the primary screen, and 12 samples of the 29 hits were identified as confirmed hits. The reaction was carried out with a different amount of the enzyme in reaction mixture containing 50 mM HEPES buffer pH 6.8, 220 mM L-glutamic acid (pH adjusted to 6.8), 7.5 mM ammonium chloride, 25 mM magnesium chloride, and 7.6 mM adenosine triphosphate (pH adjusted to 6.8) at 25°C in a 96-well plate for 2 h as mentioned in Figure 3 . The results are the average of 3 identical experiments and ±standard deviation.
Biosynthetic Activity of Mycobacterium tuberculosis Glutamine Synthetase
DISCUSSION
The major challenge in the biosynthetic assay was to substantially protect the rapid increase in color due to ATP hydrolysis under the reaction conditions used. It was clearly shown in this study that addition of citrate in the assay mix blocked a further increase in color development (Fig. 1) . Many coupled assays previously designed to carry out screening of chemical libraries are ineffective because of mainly the inability to stop this continuous increase in color. 28 In earlier studies, it was reported that the activity of this enzyme from other bacterial sources was seen to be optimum at pH 7.5. 24 We have clearly shown that for the M. tuberculosis enzyme, the affinities for the substrates are highest at the pH range of 6.8 to 6.5 ( Table 1 ). The optimum enzyme activity at pH 6.8 supports its physiological relevance for the extracellular function of the enzyme. So the screening of a chemical library on biosynthetic activity at pH 6.8 has a better prospect to get a mycobacterial glutamine synthetase inhibitor than at any other higher pH. The results also indicated that the assay protocol is robust for HTS ( Table 2) .
The HTS criteria considered here were 1) linearity of enzyme activity for more than 2 h (Fig. 3A) , 2) DMSO tolerance (Fig. 3) , and 3) reproducibility of the IC 50 value for the standard inhibitor (Fig. 4A, B) . The assay protocol was needed to successfully overcome 1 more validation step using a library consisting mainly of extracts and fractions from medicinal plants along with synthetic compounds. It was observed that many samples from natural products and synthetic libraries consist of colored molecules with poor solubility in aqueous solution. These samples caused interference in the readout during screening and increased the number of false positives and false negatives. To overcome this bottleneck, replica plates were used to obtain more accurate estimates about the interference in the readout caused by the extracts or fractions. After correction in the reading, 29 samples were picked from a set of 1164 for further confirmation studies. Without this correction, it was not possible to identify any extract/fraction as a true inhibitor of the enzyme. Two main reasons were considered in deciding the cutoff of 40% inhibition: 1) very low quantity of the active ingredient may be present in the crude extracts of the plants used and 2) the enzyme is allosteric in nature. The scattered plot and histogram of screening data clearly indicated that the protocol was robust in screening any chemical library (Fig. 5A, B) . Finally, 12 samples were identified as confirmed hits. Currently, the chromatographic separations are being carried out and guided by its inhibition of M. tuberculosis glutamine synthetase to identify the inhibitors. The results are representative of 3 identical experiments, and the ±standard deviation values are as described in Figure 3 . 
